Dual pharmacological inhibition of glutathione and thioredoxin systems synergizes to kill colorectal carcinoma stem cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual pharmacological inhibition of glutathione and thioredoxin systems synergizes to kill colorectal carcinoma stem cells
Authors
Keywords
-
Journal
Cancer Medicine
Volume 5, Issue 9, Pages 2544-2557
Publisher
Wiley
Online
2016-08-03
DOI
10.1002/cam4.844
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma
- (2016) Takayuki Shimizu et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
- (2015) Isaac S. Harris et al. CANCER CELL
- Therapeutic strategies targeting cancer stem cells
- (2015) Go J. Yoshida et al. CANCER SCIENCE
- Augmented Pentose Phosphate Pathway Plays Critical Roles in Colorectal Carcinomas
- (2015) Norisuke Shibuya et al. ONCOLOGY
- Piperlongumine Chemosensitizes Tumor Cells through Interaction with Cysteine 179 of I B Kinase, Leading to Suppression of NF- B-Regulated Gene Products
- (2014) J. G. Han et al. MOLECULAR CANCER THERAPEUTICS
- MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
- (2014) Helge Gad et al. NATURE
- Quantitative flux analysis reveals folate-dependent NADPH production
- (2014) Jing Fan et al. NATURE
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- Redox regulation in stem-like cancer cells by CD44 variant isoforms
- (2013) O Nagano et al. ONCOGENE
- Toward clinical application of the Keap1–Nrf2 pathway
- (2013) Takafumi Suzuki et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Oxidants, antioxidants and the current incurability of metastatic cancers
- (2013) J. Watson Open Biology
- The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
- (2013) Emilia Kansanen et al. Redox Biology
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Induction of the Stem-like Cell Regulator CD44 by Rho Kinase Inhibition Contributes to the Maintenance of Colon Cancer-Initiating Cells
- (2012) H. Ohata et al. CANCER RESEARCH
- Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs
- (2012) D. J. Adams et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
- (2012) P. Borst Open Biology
- CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth
- (2011) Takatsugu Ishimoto et al. CANCER CELL
- The Warburg effect in 2012
- (2011) Jean-Pierre Bayley et al. CURRENT OPINION IN ONCOLOGY
- Regulation of reactive oxygen species in stem cells and cancer stem cells
- (2011) Chiharu I. Kobayashi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- Selective killing of cancer cells by a small molecule targeting the stress response to ROS
- (2011) Lakshmi Raj et al. NATURE
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer
- (2011) J. Kondo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started